StockData
Dogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. (DWTX) stock

DWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.08+0.02 (+1.89%)

Close on Nov 17, 2026Market cap $36.71MP/E –Yield –

Dogwood Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Dogwood Therapeutics's total assets was $80.50M at Jun 30, 2026. For fiscal 2025 it was $90.17M, down 4.4% from the year before. The highest annual figure on record is $94.31M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.17M-4.4%
FY2024Dec 31, 2024$94.31M+2164.1%
FY2023Dec 31, 2023$4.17M-50.2%
FY2022Dec 31, 2022$8.37M-46.9%
FY2021Dec 31, 2021$15.78M-49.9%
FY2020Dec 31, 2020$31.47M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$80.50M-16.8%
Q1 FY2026Mar 31, 2026$95.21M-1.8%
Q4 FY2025Dec 31, 2025$90.17M-4.4%
Q3 FY2025Sep 30, 2025$91.99M+3929.0%
Q2 FY2025Jun 30, 2025$96.69M+2559.4%
Q1 FY2025Mar 31, 2025$96.98M+2907.6%
Q4 FY2024Dec 31, 2024$94.31M+2164.1%
Q3 FY2024Sep 30, 2024$2.28M-56.5%
Q2 FY2024Jun 30, 2024$3.64M-30.2%
Q1 FY2024Mar 31, 2024$3.22M-50.5%
Q4 FY2023Dec 31, 2023$4.17M-50.2%
Q3 FY2023Sep 30, 2023$5.25M-51.7%
Q2 FY2023Jun 30, 2023$5.21M-42.3%
Q1 FY2023Mar 31, 2023$6.52M-48.0%
Q4 FY2022Dec 31, 2022$8.37M-46.9%
Q3 FY2022Sep 30, 2022$10.86M-46.0%
Q2 FY2022Jun 30, 2022$9.04M-62.0%
Q1 FY2022Mar 31, 2022$12.55M-55.6%
Q4 FY2021Dec 31, 2021$15.78M-49.9%
Q3 FY2021Sep 30, 2021$20.11M–
Q2 FY2021Jun 30, 2021$23.76M–
Q1 FY2021Mar 31, 2021$28.27M–
Q4 FY2020Dec 31, 2020$31.47M–

More Dogwood Therapeutics figures

See a number that looks wrong?